Elevation Oncology, Inc. (ELEV) - Company Cash Volume

Brandmark of Elevation Oncology Inc. (ELEV)

Elevation Oncology is independently developing its oncology portfolio while seeking to establish global partnerships for distribution. The asset remains independent of economic cycles, as demand for cancer therapy is stable. However, a high cash burn rate and the risk of clinical trial failures pose a threat to the business. Current cash reserves demonstrate liquidity, with the parameter value equal to 0.08.

Company Cash Reserve: Elevation Oncology, Inc. (ELEV) for 07/04/2022 - 08/02/2025

Financial and market metric breakdowns for Elevation Oncology Inc. (ELEV)

- current price and projected stock value:
Analysis of all company metrics:ELEV Elevation Oncology
Product sample of Elevation Oncology, Inc.

Developing targeted therapies for rare cancers requires colossal expenditures on clinical trials. This indicator captures the remaining liquid assets of Elevation Oncology (ELEV), reflecting the issuer's actual financial stability. Analyzing the burn rate allows for an assessment of the business's runway before the next funding round. A high level of reserves confirms reliability but may signal stagnation in operational processes. Carefully examine the cash position history to evaluate investment risks.

Who Elevation Oncology competes with

Company Cash Volume ONC|HALO - Company Cash Reserve|Revolution Medicines - Company Cash on Hand|Company Cash Volume Ascentage Pharma AAPG|CGON - Company Cash Funds|Company Total Cash Volume URGN|BCAX: Company Cash Volume|PSNL - Company Liquid Assets|ERAS (Erasca Inc) - Company Cash Volume|Company Cash Reserve Delcath Systems Inc DCTH|Company Cash Funds YmAbs (YMAB)|Company Liquid Assets Aura Bio|Company Cash Volume CADL (Candel Therapeutics Inc.)|accuray.com (ARAY) - Company Cash Reserve|SELLAS Life Sciences Group - Company Cash Volume|ACTU - Company Cash Volume|CTOR: Company Cash Volume|Company Cash Reserve TuHURA (HURA)|TARA (Protara Therapeutics Inc) - Company Cash Volume|Fate Therapeutics, Inc. (FATE) - Company Liquid Assets|Company Cash on Hand WHWK (Aadi Bioscience, Inc.)|Company Liquid Assets TScan Therapeutics, Inc.|Company Cash Volume CSBR (Champions Oncology Corp)|Company Total Cash Amount XBIT (XBiotech USA)|CVM - Company Cash Funds|Company Cash Balance OSTX (ostherapies.com)|Radiopharm Theranostics Ltd (RADX) - Company Cash Funds|ARTV: Company Total Cash Amount|ANL (adlainortye.com) - Company Cash Volume|VERU: Company Cash Balance|Company Cash on Hand TPST (Tempest Tx)|Company Cash on Hand Xilio XLO|Company Cash Volume RENB (Renovaro)|Company Cash Volume Mural Bio MURA|Kairos Pharma Ltd - Company Cash Volume|OnKure Therapeutics (OKUR) - Company Cash on Hand|GDTC: Company Cash Volume|Curis Inc. - Company Cash Balance|Company Cash Funds apollomicsinc.com|THAR: Company Cash Balance|Company Cash Funds Advanced Biomed Corp (ADVB)|GNPX (Genprex, Inc) - Company Cash Balance|Company Cash Volume CLDI (Calidi Biotherapeutics)|sunshinebiopharma.com (SBFM) - Company Cash Reserve|Xenetic Bio - Company Cash Volume|SLRX (Salarius Pharmaceuticals, Inc.) - Company Cash and Cash Equivalents|PPBT: Company Cash Volume|Company Cash on Hand American Oncology Network Inc|BGNE (beigene.com) - Company Cash Volume|Company Cash and Cash Equivalents CKPT (Checkpoint Therapeutics)|Company Cash Funds iCAD Corp (ICAD)|Company Cash on Hand Ikena IKNA|Company Cash Volume NTBL (notablelabs.com)|VIRX - Company Cash on Hand|MOR: Company Cash on Hand|NAYA - Company Cash Volume|Ascentage Pharma (AAPGV) - Company Cash Funds